Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion type Assertion NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_head.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion description "[Topical application of a small molecular chemical inhibitor of ATX (S32826), which inhibited AH LysoPLD activity in vitro (by >90%), led to a dose-dependent and significant decrease of IOP in Dutch-Belted rabbits.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_provenance.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion evidence source_evidence_literature NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_provenance.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion SIO_000772 22916143 NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_provenance.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion wasDerivedFrom befree-20140225 NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_provenance.
- NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_assertion wasGeneratedBy ECO_0000203 NP385825.RALbfHAq_Lyz3wf-QRyDKGMfCb6c3KZAQ_VoMCBROPS0E130_provenance.